WallStreetZenWallStreetZen

NASDAQ: NATR
Natures Sunshine Products Inc Stock

$10.32+0.13 (+1.28%)
Updated Mar 17, 2023
NATR Price
$10.32
Fair Value Price
$13.14
Market Cap
$196.66M
52 Week Low
$7.93
52 Week High
$18.00
P/E
-516x
P/B
1.34x
P/S
0.38x
PEG
N/A
Dividend Yield
N/A
Revenue
$421.91M
Earnings
-$390.00k
Gross Margin
71%
Operating Margin
3.44%
Profit Margin
-0.1%
Debt to Equity
0.56
Operating Cash Flow
$710k
Beta
0.97
Next Earnings
May 3, 2023
Ex-Dividend
N/A
Next Dividend
N/A

NATR Overview

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

Zen Score

Industry Average (37)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NATR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NATR ($10.32) is undervalued by 21.48% relative to our estimate of its Fair Value price of $13.14 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NATR ($10.32) is significantly undervalued by 21.48% relative to our estimate of its Fair Value price of $13.14 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NATR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more NATR due diligence checks available for Premium users.

Be the first to know about important NATR news, forecast changes, insider trades & much more!

NATR News

Valuation

NATR fair value

Fair Value of NATR stock based on Discounted Cash Flow (DCF)
Price
$10.32
Fair Value
$13.14
Undervalued by
21.48%
NATR ($10.32) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NATR ($10.32) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NATR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NATR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-516x
Industry
31.43x
Market
21.81x

NATR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.34x
Industry
6.94x
NATR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NATR's financial health

Profit margin

Revenue
$102.7M
Net Income
$2.0M
Profit Margin
1.9%
NATR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NATR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$229.8M
Liabilities
$82.7M
Debt to equity
0.56
NATR's short-term assets ($149.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NATR's short-term assets ($149.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NATR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NATR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.6M
Investing
-$2.9M
Financing
-$941.0k
NATR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NATR vs Household & Personal Product Stocks

TickerMarket Cap1d %P/EP/B
NATR$196.66M+1.28%-516.00x1.34x
ACU$82.44M-3.48%27.09x1.04x
GROV$60.15M-2.90%-0.35x2.27x
LFVN$43.24M-0.29%-85.00x1.36x
UG$41.62M-12.88%13.94x4.16x

Natures Sunshine Products Stock FAQ

What is Natures Sunshine Products's quote symbol?

NASDAQ: NATR) Natures Sunshine Products trades on the NASDAQ under the ticker symbol NATR. Natures Sunshine Products stock quotes can also be displayed as NASDAQ: NATR.

If you're new to stock investing, here's how to buy Natures Sunshine Products stock.

What is the 52 week high and low for Natures Sunshine Products (NASDAQ: NATR)?

(NASDAQ: NATR) Natures Sunshine Products's 52-week high was $18.00, and its 52-week low was $7.93. It is currently -42.67% from its 52-week high and 30.14% from its 52-week low.

How much is Natures Sunshine Products stock worth today?

(NASDAQ: NATR) Natures Sunshine Products currently has 19,056,311 outstanding shares. With Natures Sunshine Products stock trading at $10.32 per share, the total value of Natures Sunshine Products stock (market capitalization) is $196.66M.

Natures Sunshine Products stock was originally listed at a price of $3.25 in Jun 25, 2009. If you had invested in Natures Sunshine Products stock at $3.25, your return over the last 13 years would have been 217.54%, for an annualized return of 9.29% (not including any dividends or dividend reinvestments).

How much is Natures Sunshine Products's stock price per share?

(NASDAQ: NATR) Natures Sunshine Products stock price per share is $10.32 today (as of Mar 17, 2023).

What is Natures Sunshine Products's Market Cap?

(NASDAQ: NATR) Natures Sunshine Products's market cap is $196.66M, as of Mar 20, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Natures Sunshine Products's market cap is calculated by multiplying NATR's current stock price of $10.32 by NATR's total outstanding shares of 19,056,311.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.